During the past decade, Scott and White Healthcare Round Rock conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scott and White Healthcare Round Rock" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 2 trials, followed by "Chelsea Therapeutics" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scott and White Healthcare Round Rock" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Scott and White Healthcare Round Rock" are "Stage II Breast Cancer" (3 trials), "Breast Cancer" (2 trials), "COVID-19" (2 trials), "Colon Adenocarcinoma" (2 trials) and "Dopamine Beta Hydroxylase Deficiency" (2 trials). Many other conditions were trialed in "Scott and White Healthcare Round Rock" in a lesser frequency.

Most popular intervention types in "Scott and White Healthcare Round Rock" are "Drug" (12 trials), "Other" (3 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Droxidopa" (2 trials), "Abemaciclib" (1 trials), "Anastrozole" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scott and White Healthcare Round Rock" are 14 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Scott and White Healthcare Round Rock". undefined are not yet recruiting, 1 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Scott and White Healthcare Round Rock, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Scott and White Healthcare Round Rock, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".